| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |